Our previous studies demonstrated that inflammation contributes to atherosclerosis through disruption of the low density lipoprotein receptor (LDLr) pathway. However, this effect is overridden by rapamycin, which is an inhibitor of mammalian target of rapamycin (mTOR). This study investigated the role of the mTOR pathway in atherosclerosis in vivo and in vitro.
Introduction
Cardiovascular disease, which is mainly caused by atherosclerosis, is the leading cause of global morbidity and mortality. Atherosclerosis is a chronic inflammatory disease involving endothelial dysfunction, recruitment of inflammatory cells, local production of cytokines, and lipid accumulation within the intima of the vessel wall. 1 Inflammation and dyslipidaemia play crucial, synergistic roles in the deterioration that occurs during the progression of atherosclerosis. 2, 3 However, the exact mechanisms of atherosclerosis have not been completely elucidated. 4 Recently, several lines of evidence have shown that activation of mammalian target of rapamycin (mTOR) is involved in the progression of atherosclerosis through the stimulation of vascular smooth muscle cell (VSMC) proliferation and migration and effects on cell autophagy. 5 -7 Our previous studies demonstrated that inflammation disrupts the feedback regulation of the low-density lipoprotein receptor (LDLr) and 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGR) to increase intracellular cholesterol uptake and biosynthesis, which results in intracellular lipid accumulation and foam cell formation. However, these effects were blocked by rapamycin treatment through the inhibition of SREBP-2 expression and a decrease in SREBP cleavage-activating protein (SCAP)/ SREBP-2 complex translocation from the ER to the Golgi. 2, 8 These findings
suggest that the mTOR pathway may be involved in the disruption of cholesterol homoeostasis that occurs in response to inflammatory stress. The mTOR is a serine/threonine kinase that plays important roles in regulating cellular homoeostasis and metabolism. The mTOR protein nucleates at least two distinct multi-protein complexes, namely mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). 9 The mTORC1 integrates stimulating signals and then phosphorylates p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1). This activity results in cell growth, activation of translation, and ribosome biosynthesis. 10 -12 Rapamycin and its analogues only inhibit the activity of mTORC1. 9 mTORC2 primarily modulates cell survival, cell polarity, cytoskeletal organization, and activity of the aldosteronesensitive sodium channel. 13 It has been shown that mTOR signalling regulates lipid homoeostasis by activating sterol regulatory element-binding proteins (SREBPs). 14 The mTORC1 mainly modulates insulin-mediated fatty acid synthesis by activating SREBP-1c. Insulin increases the transcription of the SREBP-1c gene, promotes the nuclear accumulation of SREBP-1c, and up-regulates the expression of lipogenic genes. 15, 16 These subsequently increase Akt activity and promote mTORC1 activation. Conversely, impairing mTORC1 activity with rapamycin blocks Akt-induced SREBP-1 nuclear localization, the expression of lipogenic genes, and the production of various classes of lipids. 17 Some studies have shown that mTORC1 is also involved in the biosynthesis and uptake of cholesterol, which is modulated by SREBP-2.
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Therefore, based on our previous work, the present study was undertaken to investigate the role of the mTOR pathway in foam cell formation using VSMCs and apolipoprotein E knockout (ApoE KO) mice under inflammatory stress.
Methods
To verify our hypothesis, several methods were used in in vitro and in vivo studies. Laser confocal microscopy was used to observe the SCAP/ SREBP-2 complex translocation from the endoplasmic (ER) to the Golgi in VSMCs measured by dual immunofluorescent staining. Real-time polymerase chain reaction (PCR), immunohistochemical staining, and western blotting were used to check the mRNA and protein expression of molecules correlated with mTOR and LDLr pathways. The mTOR siRNA transfection technology was used to knock down the expression of the mTOR gene in order to find a potential connection between the mTOR pathway and the SREBP-2-modulated LDLr pathway during foam cell formation.
Cell culture
Rat VSMCs (American Type Culture Collection, USA) were cultured with Dulbecco's Modified Eagle's Medium (DMEM) containing 10% foetal bovine serum and 2 mmol/L L-glutamine. All reagents for cell culture were obtained from Gibco Life Technologies. Lipopolysaccharide (LPS) and rapamycin were obtained from Sigma and Wyeth Pharmaceuticals, respectively. All experiments were carried out in serum-free DMEM medium containing 0.2% fatty acid-free bovine serum albumin (BSA, Sigma).
Observation of lipid accumulation
Lipid accumulation in VSMCs was evaluated by Oil Red O staining. Briefly, samples were fixed with 5% formalin solution and then stained with Oil Red O for 30 min. Finally, the samples were counterstained with haematoxylin for 5 min. The samples were then examined by a light microscopy.
mTOR siRNA transfection
VSMCs were cultured in six-well plates and transiently transfected with the mTOR siRNA or an empty vector siRNA (Cell Signaling Technologyw) using Lipofectamine 2000 (Invitrogen) in accordance with the manufacturer's protocol. Briefly, 9 mL of mTOR siRNA was mixed with 6 mL of Lipofectamine 2000 and applied to the cells. The transfected cells were incubated at room temperature for 30 min and were then seeded in a well containing 900 mL of Opti-MEM medium (Gibcow Life Technologies). At the indicated time points, the cells were harvested and examined by Oil Red O staining, immunofluorescent staining, real-time PCR, western blotting, and flow cytometry.
Confocal microscopy
Rat VSMCs cultured in 24-well plates were washed, fixed, and permeabilized. The cells were then incubated with a goat anti-rat SCAP antibody (1:100 dilution) and a rabbit anti-rat Golgi antibody (1:100 dilution) followed by the secondary antibodies donkey anti-goat Fluor 488 and donkey anti-rabbit Fluor 594, respectively (Invitrogen, USA). After washing, the cells were examined by a laser confocal microscopy (×400).
Cell cycle observation
Rat VSMCs were harvested and washed with phosphate-buffered saline (PBS). The cells were then fixed with 70% ethanol. Immediately prior to the analysis, the cells were incubated for 30 min at 378C in fresh propidium iodide solution containing RNase A. A total of 10 4 cells were analysed from each sample on a Calibur Flow fluorescence-activated cell sorting cytometer (Becton Dickinson, USA).
Real-time reverse transcription polymerase chain reaction
Total RNA was isolated from cells using the guanidinium-phenol -chloroform method. Real-time reverse transcription PCR was performed in an ABI 7300 Sequence Detection System using SYBR Green dye in accordance with the manufacturer's protocol. All Taqman primers (Sigma-Genosys, USA) were designed using the Primer Express Software V2.0 (Applied Biosystems, USA) ( Table 1 ). gel electrophoresis. Gel transfer was performed, and the membranes were blocked with blocking buffer for 1 h at room temperature. The membranes were then incubated overnight at 48C with anti-rat antibodies against mTOR, phosphorylated-mTOR (p-mTOR), 4EBP1, phosphorylated-4EBP1 (p-4EBP1), S6K1, phosphorylated-S6K1 (p-S6K1) (Abcam, UK), LDLr, SREBP-2, SCAP, the retinoblastoma tumour suppressor protein (Rb), and phosphorylated-Rb (p-Rb) (Santa Cruz, USA). This was followed by incubation with horseradish peroxidase-conjugated secondary antibodies for a further hour at 48C. Finally, the signals were detected using the ECL Advance system (Amersham Biosciences, USA).
Western blotting

Animal model
Male ApoE KO mice with a C57BL/6 genetic background were studied under protocols approved by the Ethics Committee of Southeast University. Eight-week-old ApoE KO mice were randomly assigned to daily subcutaneous injections of 0.5 mL PBS (control), 8 mg/kg/q.o.d rapamycin (Rapa), 10% casein (casein), or rapamycin plus casein (casein plus Rapa). The mice were fed the western diet (Harlan, TD88137) containing 21% fat and 0.15% cholesterol for 8 weeks. At termination, the mice were humanely killed by 0.3 mL 10% phenobarbitone injection, blood samples were taken for serum amyloid A (SAA) and tumour necrosis factor-a (TNF-a) assays, and aorta samples were taken for histological assessment.
Enzyme-linked immunosorbent assay
The serum levels of SAA and TNF-a were measured using kits (Invitrogen, USA).
Lipid profile assay
The serum concentrations of triglycerides (TG), total cholesterol (TC), LDL, and high-density lipoprotein (HDL) in ApoE KO mice were determined using automatic analysers (Hitachi, Japan).
Tissue processing
The aorta tissue sections were rinsed with saline and placed in 10% buffered formalin. After treatment, representative sections of the specimen were obtained and embedded in either O.C.T. medium or paraffin wax.
Observation of lipid accumulation
Lipid accumulation in VSMCs or in the aorta of ApoE KO mice was evaluated by Oil Red O staining. Briefly, samples were fixed with 5% formalin solution and then stained with Oil Red O for 30 min. Finally, the samples were counterstained with haematoxylin for 5 min. The samples were then examined by a light microscopy.
Immunohistochemical staining
The paraffin-embedded tissue samples were sectioned at a thickness of 4 mm. The sections were then placed in citrate-buffered solution (pH 6.0) and heated for antigen retrieval. Endogenous peroxidase activity was blocked by incubation with 3% hydrogen peroxide, and non-specific binding was blocked by incubation with 10% goat serum. Subsequently, the sections were incubated with rabbit anti-mouse primary antibodies against mTOR, p-mTOR, 4EBP1, p-4EBP1, S6K1, p-S6K1, and LDLr (Abcam, UK) overnight at 48C, followed by incubation with a biotinylated secondary antibody. Finally, diaminobenzidine tetrahydrochloride substrate was used to produce a colour reaction. The results of this staining were observed under a light microscope (×200 magnification).
Data analysis
All of the data are expressed as the means + standard deviation (SD) and were analysed with SPSS 13.0. Continuous variables were compared between the two groups with the independent sample t-test where appropriate. A difference was considered significant if the P-value was ,0.05.
Results
Inhibition of the mTOR pathway decreased lipid accumulation
Using ApoE KO mice, we induced an inflamed atherosclerotic model with a combination of a western diet and subcutaneous injection of 10% casein. As shown in Figure 1A and B, the significantly increased serum levels of SAA and TNF-a in casein-injected mice confirmed the successful induction of an inflamed atherosclerotic model. We then checked the serum lipid profile using clinical biochemistry assays. The results showed that there was a significant hypolipidaemia characterized by decreased serum levels of TC, TG, LDL, and HDL in the casein-injected mice compared with the controls ( Figure 1C) . Interestingly, inflammatory stress-induced lipid accumulation in the aorta in casein-injected mice ( Figure 1D ) and in LPS-stimulated VSMCs ( Figure 1E ) as demonstrated by Oil Red O staining. However, inhibition of the mTOR pathway by either rapamycin treatment or mTOR siRNA prevented foam cell formation and lipid accumulation in vivo ( Figure 1D ) and in vitro ( Figure 1E ). VSMCs were incubated for 24 h either in serum-free medium (Control), or in serum-free medium containing 100 nmol/L of mTOR siRNA (simTOR). The mRNA expression of LDLr, SREBP-2, and SCAP were determined by real-time PCR. b-Actin served as an internal control gene. The results represented the means + SD from three experiments. *P , 0.05 vs. Control; **P , 0.001 vs. Control. (D and E) VSMCs were incubated for 24 h in serum-free medium (Control) or in serum-free medium containing 100 nmol/L of mTOR siRNA (simTOR). The protein expression of LDLr, nuclear SREBP-2 (nSREBP-2), and SCAP were determined by western blotting. The histogram shows the means + SD of the densitometric scans of the LDLr, SREBP-2, and SCAP protein bands from three experiments following normalization by comparison with b-actin. *P , 0.05 vs. Control; **P , 0.001 vs. Control. (F) The translocation of SCAP escorting SREBP-2 from the ER to the Golgi in VSMCs. VSMCs were cultured for 24 h in serum-free medium (Control), or in serum-free medium containing 25 mg/mL of lipopolysaccharide alone (LPS), 10 ng/mL of rapamycin alone (Rapa) or 25 mg/mL of LPS plus 10 ng/ mL of rapamycin (LPS plus Rapa), or in serum-free medium containing 100 nmol/L of mTOR siRNA (simTOR). Following immunostaining of the cells, the immunofluorescent signals were detected by confocal microscopy.
Inhibition of the mTOR pathway down-regulated the expression of LDLr pathway components induced by inflammation
To explore the possible mechanisms underlying the anti-atherosclerotic effects of mTOR pathway inhibition, we observed the effects of mTOR inhibition on the LDLr pathway under inflammatory stress in vivo and in vitro. Immunohistochemical staining showed that inflammation significantly increased LDLr protein expression in the aorta in casein-injected mice compared with the controls (Figure 2A) . However, rapamycin, an inhibitor of mTOR, blocked the increase of LDLr protein expression (Figure 2A) . Results from in vitro studies further confirmed that mTOR inhibition, through treatment with rapamycin or mTOR siRNA, downregulated the mRNA and protein expression levels of LDLr, SREBP-2, and SCAP in VSMCs in which the inflammatory response was induced by LPS ( Figure 2B-E) . Using dual immunofluorescent staining with antibodies against SCAP and the Golgi, we demonstrated that inflammation increased SCAP accumulation in the Golgi, whereas mTOR inhibition by rapamycin or mTOR siRNA reduced it ( Figure 2F ). These results suggest that the mTOR pathway regulates LDLr gene transcription by affecting the translocation of the SCAP/SREBP-2 complex from the ER to the Golgi. The expression levels of the unphosphorylated and phosphorylated forms of mTOR, 4EBP1, and S6K1 were examined by immunostaining of cross-sections of aortas taken from ApoE KO mice. Brown staining indicates areas of expression of the protein examined (×200 magnification).
Inflammation induced activation of the mTOR pathway
We then investigated the effects of inflammation on mTOR pathway activation, which may be one of the potential mechanisms for the inflammation-mediated disruption of the LDLr pathway. The results from in vivo and in vitro studies showed that inflammation increased the mRNA expression levels and phosphorylated protein expression levels of mTOR, 4EBP1, and S6K1. Conversely, these effects were inhibited by rapamycin treatment and by mTOR siRNA (Figures 3 and 4A-F ) , which suggests that the mTOR pathway is activated by inflammation.
Inflammation-mediated activation of mTOR contributes to the disruption of the LDLr pathway through Rb phosphorylation
mTOR is an important protein kinase that modulates the cell cycle and DNA synthesis. Therefore, we examined the effects of mTOR pathway activation in VSMCs on the cell cycle protein Rb, which may be involved in the disruption of LDLr feedback regulation that results from mTOR activation. Flow cytometry analysis demonstrated that inflammation increased the percentage of cells in the S phase of cell cycle and contributed to cell cycle progression in VSMCs. This effect was blocked by treatment with rapamycin ( Figure 5A and B) . Immunofluorescent staining showed that inflammation increased the expression of the phosphorylated Rb protein, and this effect was inhibited by rapamycin ( Figure 5C ). The results of real-time RT-PCR and western blotting analyses of VSMCs demonstrated that inflammation increased both the mRNA expression level of Rb and the level of phosphorylated Rb protein, and these effects were again inhibited by rapamycin treatment or mTOR siRNA ( Figure 6A-F) . These findings were in accordance with those from immunofluorescent staining.
Discussion
In this study, we observed the role of the mTOR pathway in foam cell formation using a VSMC-based cell culture model. The results showed that inflammation significantly induced lipid accumulation in VSMCs. However, mTOR inhibition with rapamycin or mTOR siRNA overrode these effects of inflammation, and this observation agrees with those observed in our previous studies 2, 8 and suggests that the mTOR pathway may be involved in atherogenesis.
To clarify the potential connection among inflammation, cholesterol homoeostasis, and the mTOR pathway, we examined the LDLr pathway, which is subject to feedback regulation modulated by SREBP-2. SREBP-2 is synthesized in the ER in the form of a precursor protein, and its activation depends on SCAP. When cells are depleted of cholesterol, SCAP escorts SREBP-2 from the ER to the Golgi where SREBP-2 is cleaved to produce its nuclear form. Nuclear SREBP-2 is transported to the nucleus, thereby activating LDLr gene transcription to increase cholesterol uptake. When cells are overloaded with cholesterol, SREBP-2 resides in the ER, and cholesterol uptake is suppressed. 21 Our results show that inflammation up-regulates LDLr, SREBP-2, and SCAP expression and increases the translocation of the SCAP/ SREBP-2 complex from the ER to the Golgi, which suggests that LDLr feedback regulation is disrupted under these conditions. However, mTOR inhibition by rapamycin or by mTOR siRNA overrode the disruption of the LDLr pathway that results from inflammation. Therefore, we assumed that a potential mechanism for the disruption of the LDLr pathway could involve the activation of mTOR. A similar report by Ai et al. 22 recently showed that increased hepatic mTORC1 activity up-regulated LDLr expression in the liver of C57BL/6 mice. Thus, we examined the effect of inflammation on the activation of the mTOR pathway in VSMCs. The results of our experiments demonstrate that inflammation increases the expression of the phosphorylated forms of mTOR, 4EBP1, and S6K1. Treatment with rapamycin or with mTOR siRNA was found to suppress these effects. Song et al. 23 recently
found that the pro-inflammatory cytokine IL-6 mediates the induction of mTORC1 activity. Lim et al. 24 demonstrated that phosphatidic acid activates Akt-dependent mTOR-p70 S6 kinase in RAW264.7 cells and that this is mainly mediated by excreted inflammatory cytokines (IL-1b, IL-6, TNF-a, and inducible nitric oxide stimulated by phosphatidic acid). Glantschnig et al. 25 also demonstrated that cytokine signalling [M-CSF, TNF-a, and receptor activator of NF kappa B (RANK)] promotes mTOR/ribosomal protein S6 kinase activation. Taken together, our findings and those of others clearly show that inflammatory stress induces the activation of the mTOR pathway. It is well-known that the mTOR pathway plays crucial roles in regulating cell cycle progression. 26 The Rb protein is a critical component of the cell cycle control machinery. 27 Rb governs entry into the S phase, and some studies have reported that mTOR kinase phosphorylates Rb to drive cell cycle progression during cell growth and proliferation. 28, 29 Furthermore, inflammation also plays an important role in directly inducing Activation of mTOR pathway and foam cell formation the phosphorylation of Rb. Nathe et al. 30 reported that IL-1b increases Rb phosphorylation to drive cells through the G1-to-S transition in the cell cycle. Bengoechea-Alonso et al. 31 showed that the modulation of cholesterol trafficking-related genes (LDLr, HMGR, and fatty acid synthase) depends on the hyperphosphorylation of nuclear SREBP at the M phase of the cell cycle. Therefore, we hypothesized that mTOR activation may increase SREBP-2-mediated cholesterol uptake via Rb phosphorylation. Our results showed that inflammation increased the percentage of S phase cells in the cell cycle distribution and increased the expression of phosphorylated Rb protein. Interestingly, after treatment with rapamycin or with mTOR siRNA, phosphorylated Rb protein expression was decreased. Accordingly, the expression of LDLr, SCAP, and SREBP-2 and the translocation of SCAP/SREBP-2 complex from the ER to the Golgi were also decreased. This suggests that mTOR activation induced by inflammation may contribute to SREBP-2-mediated cholesterol uptake through Rb phosphorylation.
As rapamycin is an mTORC1 inhibitor, SREBP-2-mediated cholesterol uptake may be correlated with increased mTORC1 activity. 18 demonstrated that mTORC1 regulates SREBP-1-mediated fatty acid synthesis by controlling the nuclear entry of lipin 1. Ai et al. 22 found that increased mTORC1 activity up-regulates hepatic LDL receptor expression, which is modulated by SREBP-2, via the activation of protein kinase C d. In this study, our findings demonstrate for the first time that inflammation disrupts LDLr feedback regulation through the activation of the mTOR pathway. Increased mTORC1 activity up-regulates SREBP-2-mediated cholesterol uptake through Rb phosphorylation. This may represent a newly identified mechanism for foam cell formation in atherosclerosis and may also provide more evidence for the prevention of atherosclerosis progression using inhibitors of mTOR C1 activity in cardiovascular patients.
